Women’s Health Diagnostics Market
Women's Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-Users (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period, (2026-2035)
Industry Overview
women’s health diagnostics market was valued at $20,120.5 million in 2025 and is projected to reach $42,363.8 million by 2035, growing at a CAGR of 7.8% during the forecast period (2026-2035). The global women’s health diagnostics market is progressing steadily as healthcare systems and diagnostic providers intensify their focus on early detection, preventive screening, and personalized care across the female lifespan. Growth is being reinforced by rising awareness of women-specific conditions, expanding adoption of advanced diagnostic technologies such as molecular diagnostics, imaging systems, and point-of-care testing, and the integration of digital health platforms that enhance diagnostic accuracy and workflow efficiency. Demand is further supported by increasing screening initiatives for breast, cervical, and reproductive health disorders, alongside a growing burden of chronic and age-related conditions among women. As healthcare authorities emphasize timely diagnosis and evidence-based clinical decision-making, women’s health diagnostics solutions are becoming indispensable in improving patient outcomes, reducing disease progression, and supporting cost-effective care delivery.
Market Dynamics
Rising Emphasis on Preventive Screening and Early Diagnosis in Women’s Healthcare
Healthcare providers and public health systems are increasingly prioritizing early detection and preventive screening to address the growing burden of women-specific diseases. Expanding awareness programs for breast cancer, cervical cancer, reproductive health disorders, and prenatal conditions are driving higher utilization of diagnostic tests across clinical settings. The shift toward preventive care is encouraging the adoption of advanced diagnostic solutions that enable accurate, timely, and cost-effective detection. Providers are focusing on technologies that support improved clinical decision-making while reducing long-term treatment costs. This growing emphasis on proactive women’s healthcare is emerging as a significant factor shaping global market expansion.
Advancing Adoption of Innovative Diagnostic Technologies and Integrated Care Models
Technological advancements in molecular diagnostics, imaging systems, point-of-care testing, and digital health tools are transforming women’s health diagnostics workflows. Automation, enhanced assay sensitivity, and AI-assisted imaging analytics are enabling faster turnaround times and improved diagnostic precision. Diagnostic manufacturers are increasingly developing integrated platforms that support seamless data management, remote monitoring, and interoperability across care settings. These innovations are helping healthcare organizations improve operational efficiency without extensive infrastructure overhauls. As a result, the continued integration of advanced and technology-driven diagnostic solutions is acting as a key growth driver for the global women’s health diagnostics market.
Market Segmentation
- Based on the application, the market is segmented into breast cancer testing, cervical cancer testing, pregnancy & fertility testing, ovarian cancer testing, infectious disease testing, ultrasound tests, sexually transmitted disease testing, and others.
- Based on the end-user, the market is segmented into diagnostic and imaging centers, hospitals and clinics, and home care.
Breast Cancer Testing Segment to Lead the Market with the Largest Share
The breast cancer testing segment is emerging as the most dominant component of the global women’s health diagnostics market, driven by the high prevalence of breast cancer and the strong emphasis on early detection and routine screening. Healthcare providers increasingly rely on advanced imaging technologies, molecular diagnostics, and biomarker-based tests to improve diagnostic accuracy and enable timely clinical intervention. The widespread implementation of national screening programs, coupled with growing awareness among women, is further strengthening demand for breast cancer diagnostics. Continuous advancements in mammography, ultrasound, and companion diagnostic tools are enhancing detection rates while reducing false positives. As early diagnosis remains central to improving survival outcomes, this segment continues to anchor the largest share of the market.
Hospitals and Clinics: A Key End-User Segment Driving Market Growth
Hospitals and clinics remain the primary end users in the women’s health diagnostics market, supported by their role as the first point of care for screening, diagnosis, and treatment planning. These settings benefit from access to advanced diagnostic infrastructure, skilled healthcare professionals, and integrated care pathways that support comprehensive women’s health services. Increasing patient footfall for routine check-ups, prenatal testing, and cancer screening is driving higher adoption of diagnostic solutions within hospitals and clinics. Additionally, ongoing investments in diagnostic imaging systems and laboratory automation are improving efficiency and throughput. Collectively, these factors reinforce the strong influence of hospitals and clinics in shaping overall market growth.
Regional Outlook
The global women’s health diagnostics market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Expanding Women’s Healthcare Infrastructure Across Asia-Pacific
Asia-Pacific is witnessing robust growth in the women’s health diagnostics market as healthcare systems, diagnostic providers, and government bodies intensify efforts to improve access to women-focused care. Rising investments in healthcare infrastructure, coupled with increasing awareness of early disease detection, are supporting wider adoption of diagnostic solutions across both urban and emerging markets. National screening programs for breast and cervical cancer, along with initiatives targeting maternal and reproductive health, are accelerating demand for reliable and scalable diagnostic technologies. Regional manufacturers and global players are expanding their presence by offering cost-effective and technologically advanced solutions tailored to diverse patient populations. As healthcare priorities continue to shift toward preventive and value-based care, Asia-Pacific is building a strong foundation for sustained growth in women’s health diagnostics.
North America Region Dominates the Market with Major Share
North America holds a leading position in the global women’s health diagnostics market, supported by a well-established healthcare infrastructure and strong emphasis on early disease detection and preventive care. The region benefits from widespread adoption of advanced diagnostic technologies, including molecular diagnostics, imaging systems, and point-of-care testing solutions. Increasing awareness initiatives, routine screening programs for breast and cervical cancer, and favorable reimbursement frameworks are further driving diagnostic uptake. Strong collaboration between diagnostic manufacturers, healthcare providers, and research institutions continues to accelerate innovation and product adoption. In addition, regulatory focus on evidence-based diagnosis and quality standards reinforces the region’s reliance on advanced women’s health diagnostics, collectively sustaining North America’s dominant market share.
Market Players Outlook
The major companies operating in the global women’s health diagnostics market include Abbott Laboratories Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Thermo Fisher Scientific Inc. among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In June 2025, Roche Diagnostics expanded its women’s health diagnostics portfolio with the launch of an advanced molecular screening solution designed to improve early detection of cervical and breast cancer. The platform integrates enhanced biomarker sensitivity with automated data interpretation, supporting faster and more accurate clinical decision-making in routine screening programs.
- In April 2025, Hologic, Inc. introduced an upgraded AI-enabled imaging and diagnostics suite for women’s health, aimed at improving diagnostic accuracy in breast and gynecological applications. The solution enhances workflow efficiency across hospitals and diagnostic centers while supporting earlier disease identification through advanced analytics and imaging capabilities.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global women’s health diagnostics Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Women’s Health Diagnostics Market Sales Analysis – Application | End-Users ($ Million)
- Women’s Health Diagnostics Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Women’s Health Diagnostics Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Women’s Health Diagnostics Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Women’s Health Diagnostics Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Women’s Health Diagnostics Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Women’s Health Diagnostics Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Women’s Health Diagnostics Market Revenue and Share by Manufacturers
- Women’s Health Diagnostics Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Koninklijke Philips N.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Quest Diagnostics Incorporated
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Abbott Laboratories Inc.
- Key Company Analysis
- Global Women’s Health Diagnostics Market Sales Analysis by Application ($ Million)
- Breast Cancer Testing
- Cervical Cancer Testing
- Pregnancy & Fertility Testing
- Ovarian Cancer Testing
- Infectious Disease Testing
- Ultrasound Tests
- Sexually Transmitted Disease Testing
- Others
- Global Women’s Health Diagnostics Market Sales Analysis by End-Users ($ Million)
- Diagnostic and Imaging Centers
- Hospitals and Clinics
- Home Care
- Regional Analysis
- North American Women’s Health Diagnostics Market Sales Analysis – Application | End-Users | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Women’s Health Diagnostics Market Sales Analysis – Application | End-Users | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Women’s Health Diagnostics Market Sales Analysis – Application | End-Users | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Women’s Health Diagnostics Market Sales Analysis – Application | End-Users | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- bioMérieux SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Canon Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Carestream Health, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Chembio Diagnostic Systems, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cook Medical Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FUJIFILM Holdings Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE HealthCare Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hologic, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PerkinElmer, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Quest Diagnostics Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shimadzu Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sysmex Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- URIT Medical Electronic Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories Inc.
1. Global Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
2. Global Breast Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Cervical Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Pregnancy & Fertility Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Ovarian Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Infectious Disease Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Ultrasound Tests Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Sexually Transmitted Disease Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Others Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
11. Global Women’s Health Diagnostics for Diagnostic and Imaging Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Women’s Health Diagnostics for Hospitals and Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Women’s Health Diagnostics for Home Care Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
15. North American Women’s Health Diagnostics Market Research and Analysis by Country, 2025–2035 ($ Million)
16. North American Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
17. North American Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
18. European Women’s Health Diagnostics Market Research and Analysis by Country, 2025–2035 ($ Million)
19. European Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
20. European Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
21. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by Country, 2025–2035 ($ Million)
22. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
23. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
24. Rest of the World Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
25. Rest of the World Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
26. Rest of the World Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
1. Global Women’s Health Diagnostics Market Share by Application, 2025 Vs 2035 (%)
2. Global Breast Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
3. Global Cervical Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
4. Global Pregnancy & Fertility Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
5. Global Ovarian Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
6. Global Infectious Disease Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
7. Global Ultrasound Tests Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
8. Global Sexually Transmitted Disease Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
9. Global Others Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
10. Global Women’s Health Diagnostics Market Share by End-Users, 2025 Vs 2035 (%)
11. Global Women’s Health Diagnostics for Diagnostic and Imaging Centers Market Share by Region, 2025 Vs 2035 (%)
12. Global Women’s Health Diagnostics for Hospitals and Clinics Market Share by Region, 2025 Vs 2035 (%)
13. Global Women’s Health Diagnostics for Home Care Market Share by Region, 2025 Vs 2035 (%)
14. Global Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
15. US Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
16. Canada Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
17. UK Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
18. France Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
19. Germany Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
20. Italy Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
21. Spain Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
22. Russia Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
23. Rest of Europe Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
24. India Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
25. China Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
26. Japan Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
27. South Korea Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
28. Australia and New Zealand Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
29. ASEAN Economies Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
30. Rest of Asia-Pacific Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
31. Latin America Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
32. Middle East and Africa Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Women’s Health Diagnostics Market in 2025 is estimated to be around $20,120.5 million.
North America holds the largest share in the Women’s Health Diagnostics Market.
Leading players in the Women’s Health Diagnostics Market include Abbott Laboratories Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Thermo Fisher Scientific Inc. among others.
The Women’s Health Diagnostics Market is expected to grow at a CAGR of 7.8% from 2026 to 2035.
The Women’s Health Diagnostics Market growth is driven by increasing awareness of preventive healthcare and rising demand for early detection and screening of women-specific diseases.
